RS

Rajanna Suma

Active Director Director DIN 07858938
DIN 07858938 First appointment Mar 2018 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value •••• Premium profile

About Rajanna Suma

Data last updated:

Rajanna Suma is a Director at G5 Biotech Private Limited (since 2018). The company operates in Life Sciences. G5 Biotech Private Limited reported revenue of ₹91,862 (FY 2022).

DIN 07858938
Primary Designation Director
Industry Life Sciences
First Appointment 22 Mar 2018
Oldest Company Age 8 yrs
Largest company G5 Biotech Private Limited · ₹91,862 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
G5 Biotech Private Limited U74999KA2018PTC111526
Director22 Mar 20182018₹91,862 (FY 2022)Active

Board colleagues of Rajanna Suma

NameDINCompanyDesignation
Bijawara Kenchappa Girish Babu06505568G5 Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
G5 Biotech Private Limited
Premium access

Shareholding and investment profile for Rajanna Suma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajanna Suma

Rajanna Suma currently holds 1 directorship: G5 Biotech Private Limited (Director, since 22 Mar 2018, revenue ₹91,862 (FY 2022)).

Rajanna Suma was first appointed on 22 Mar 2018 as Director at G5 Biotech Private Limited.

The current boards of Rajanna Suma's companies include Bijawara Kenchappa Girish Babu (G5 Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available